95 related articles for article (PubMed ID: 22391162)
1. [Effects of interferon-α combined with homoharringtonine on K562 cell proliferation and β-catenin expression].
Shi YY; Cao WK; Liu XN; Deng ZK; Guo H; Feng WT; Ye LL; Zhu JB; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Feb; 20(1):43-7. PubMed ID: 22391162
[TBL] [Abstract][Full Text] [Related]
2. [Combined Effect of Bortezomib and Homoharringtonine on K562 Cells and their Mechanisms].
Xie C; Tang AP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):395-400. PubMed ID: 29665904
[TBL] [Abstract][Full Text] [Related]
3. Effects of homoharringtonine alone and in combination with alpha interferon and cytosine arabinoside on 'in vitro' growth and induction of apoptosis in chronic myeloid leukemia and normal hematopoietic progenitors.
Visani G; Russo D; Ottaviani E; Tosi P; Damiani D; Michelutti A; Manfroi S; Baccarani M; Tura S
Leukemia; 1997 May; 11(5):624-8. PubMed ID: 9180282
[TBL] [Abstract][Full Text] [Related]
4. [Effects of Homoharringtonine Combined with Imatinib on K562 Cell Apoptosis and BCL6 expression].
Wang Q; Ding W; Wu JJ; Ding YH; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1716-1720. PubMed ID: 28024482
[TBL] [Abstract][Full Text] [Related]
5. Homoharringtonine induces apoptosis of endothelium and down-regulates VEGF expression of K562 cells.
Ye XJ; Lin MF
J Zhejiang Univ Sci; 2004 Feb; 5(2):230-4. PubMed ID: 14674038
[TBL] [Abstract][Full Text] [Related]
6. [Effect of homoharringtonine on expression of NF-κB and BCL-2 proteins in K562 cells].
Ye LL; Cao WK; Shi YY; Deng ZK; Tao SD; Ji P; Fu XH; Zong MZ; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):78-81. PubMed ID: 23484696
[TBL] [Abstract][Full Text] [Related]
7. [Time rhythm of homoharringtonine inducing K562 cell apoptosis and its mechanism].
Lu XY; Cao WK; Ye LL; Deng ZK; Zhang XH; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun; 22(3):712-6. PubMed ID: 24989282
[TBL] [Abstract][Full Text] [Related]
8. [Effect of Autophagy on Homoharringtonine-treated K562 Cells].
Lu XY; Ye LL; Shi YY; Ding YH; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):412-417. PubMed ID: 28446285
[TBL] [Abstract][Full Text] [Related]
9. [Effect of Homoharringtonine Combined with Imatinib on the K562/G01 Cells and Its Mechanism].
Wu JJ; Ding YH; Deng ZK; Shi YY; Lu XY; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):80-84. PubMed ID: 28245379
[TBL] [Abstract][Full Text] [Related]
10. [Mechanism of mTOR Pathway in K562 cell Apoptosis Induced by Homoharringtonine].
Ding YH; Wu JJ; Wang Q; Deng ZK; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):105-109. PubMed ID: 29397826
[TBL] [Abstract][Full Text] [Related]
11. [Influence of celecoxib combined with IFN-alpha on proliferation, apoptosis, cell cycle and CD117 expression of K562 cells].
Xie ZN; Liu DS; Cao WK; Deng ZK; Li YF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Apr; 18(2):330-4. PubMed ID: 20416162
[TBL] [Abstract][Full Text] [Related]
12. [Changes of gene expression profile in homoharringtonine-induced leukemia multi-drug resistant cell line K562/HHT].
Yu XL; Liu Y; Wang JD; Kong DX; Chen CY
Zhonghua Xue Ye Xue Za Zhi; 2009 Jun; 30(6):363-7. PubMed ID: 19951526
[TBL] [Abstract][Full Text] [Related]
13. Induction of apoptosis by homoharringtonine in G1 phase human chronic myeloid leukemic cells.
Mai WY; Lin MF
Chin Med J (Engl); 2005 Mar; 118(6):487-92. PubMed ID: 15788130
[TBL] [Abstract][Full Text] [Related]
14. MiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1.
Zhou M; Zeng J; Wang X; Guo Q; Huang T; Shen H; Fu Y; Wang L; Jia J; Chen C
J Transl Med; 2013 Oct; 11():265. PubMed ID: 24148180
[TBL] [Abstract][Full Text] [Related]
15. [Effects of beta-catenin-specific siRNA interference on Jurkat and K562 cells].
Mai YJ; Qiu LG; Li ZJ; Li X; Yu Z; Li CH; Wang YF; Li Q
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Jun; 30(3):290-5. PubMed ID: 18686607
[TBL] [Abstract][Full Text] [Related]
16. Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.
Chen J; Mu Q; Li X; Yin X; Yu M; Jin J; Li C; Zhou Y; Zhou J; Suo S; Lu D; Jin J
Oncotarget; 2017 Jun; 8(25):40318-40326. PubMed ID: 28454099
[TBL] [Abstract][Full Text] [Related]
17. Synergistic Effect and Molecular Mechanism of Homoharringtonine and Bortezomib on SKM-1 Cell Apoptosis.
Zhang J; Chen B; Wu T; Wang Q; Zhuang L; Zhu C; Fan N; Qing W; Ma Y; Xu X
PLoS One; 2015; 10(11):e0142422. PubMed ID: 26544558
[TBL] [Abstract][Full Text] [Related]
18. Anti-myeloma effect of homoharringtonine with concomitant targeting of the myeloma-promoting molecules, Mcl-1, XIAP, and beta-catenin.
Kuroda J; Kamitsuji Y; Kimura S; Ashihara E; Kawata E; Nakagawa Y; Takeuichi M; Murotani Y; Yokota A; Tanaka R; Andreeff M; Taniwaki M; Maekawa T
Int J Hematol; 2008 Jun; 87(5):507-515. PubMed ID: 18415656
[TBL] [Abstract][Full Text] [Related]
19. [Effects of Triptolide Combined with Homoharringtonine on Proliferation and Apoptosis of KG-1α Cells].
Li X; Liu JY; Yuan XH; Lin ZX; Wu Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):347-353. PubMed ID: 29665897
[TBL] [Abstract][Full Text] [Related]
20. Long-term effect of interferon-α combined with homoharringtonine on chronic myelogenous leukemia in chronic phase.
Zhu J; Ding B; Li Y
Leuk Lymphoma; 2013 Jul; 54(7):1426-9. PubMed ID: 23270584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]